Clinical trials
Completed Phase 3 Diabetes Mellitus, Type 2 trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
1,013 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 12 |
| 2001 | 17 |
| 2002 | 17 |
| 2003 | 28 |
| 2004 | 54 |
| 2005 | 51 |
| 2006 | 69 |
| 2007 | 45 |
| 2008 | 71 |
| 2009 | 61 |
| 2010 | 77 |
| 2011 | 55 |
| 2012 | 60 |
| 2013 | 61 |
| 2014 | 47 |
| 2015 | 37 |
| 2016 | 42 |
| 2017 | 32 |
| 2018 | 12 |
| 2019 | 26 |
| 2020 | 28 |
| 2021 | 20 |
| 2022 | 20 |
| 2023 | 28 |
| 2024 | 18 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 1,013 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 162 |
| AstraZeneca | 95 |
| Eli Lilly and Company | 73 |
| Merck Sharp & Dohme LLC | 73 |
| Sanofi | 66 |
| Boehringer Ingelheim | 47 |
| Novartis Pharmaceuticals | 32 |
| Takeda | 31 |
| Novartis | 30 |
| GlaxoSmithKline | 25 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 1,013 |
| Diabetes Mellitus | 284 |
| Obesity | 35 |
| Glucose Metabolism Disorders | 34 |
| Insulin Resistance | 33 |
| Dyslipidemias | 30 |
| Diabetes Mellitus, Type 1 | 20 |
| Hyperglycemia | 18 |
| Hypertension | 18 |
| Metabolic Diseases | 15 |
Trials
Showing 1 to 25 of 1,013. Each trial links to its page on Pharma Observatory.
913 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.